You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ATR inhibition

Showing 1 - 25 of 2,941
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell

Not yet recruiting
  • Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +5 more
  • (no location specified)
Jul 13, 2023

Prostate Cancer Trial in Ann Arbor, Detroit, Charlottesville (Olaparib, AZD6738)

Active, not recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +2 more
Jan 9, 2023

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

Oesophageal Adenocarcinoma, Squamous Cell Carcinoma, Solid Tumor Trial in United Kingdom (M6620, Cisplatin, Capecitabine)

Completed
  • Oesophageal Adenocarcinoma
  • +2 more
  • Cardiff, United Kingdom
  • +4 more
Apr 27, 2022

SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

Recruiting
  • SCLC
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Healthy Trial in Neu-Ulm (ATR-002, Placebo, Repaglinide)

Recruiting
  • Healthy
  • Neu-Ulm, Germany
    Atriva study site
Sep 22, 2022

Leiomyosarcoma, Adult Trial in France (Association of berzosertib with gemcitabine, Gemcitabine)

Recruiting
  • Leiomyosarcoma, Adult
  • Bordeaux, France
  • +5 more
Jul 27, 2022

Refractory Prostate Carcinoma Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Refractory Prostate Carcinoma
  • Biopsy
  • +6 more
  • (no location specified)
Apr 25, 2023

HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

Recruiting
  • HRD Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma Trial in United

Active, not recruiting
  • Metastatic Fallopian Tube Carcinoma
  • +11 more
  • Phoenix, Arizona
  • +13 more
Dec 2, 2022

Advanced Solid Tumor, Recurrent Endometrial Cancer, Metastatic Cancer Trial (ART0380)

Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • (no location specified)
Apr 5, 2023

Triple Negative Breast Cancer Metastatic Trial in Milano, Padova (Ceralasertib, Durvalumab, Nab-paclitaxel)

Recruiting
  • Triple Negative Breast Cancer Metastatic
  • Milano, Italy
  • +1 more
Jan 16, 2023

Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Active, not recruiting
  • Advanced Breast Cancer
  • +2 more
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University Hospitals and Clinics
Nov 16, 2022

Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

Completed
  • Mesothelioma
  • +3 more
  • Gainesville, Florida
  • +2 more
Jan 4, 2023

Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)

Completed
  • Refractory Cancer
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Tumors Trial in Bethesda, Boston, Houston (Veliparib + VX-970 + Cisplatin)

Completed
Has Results
  • Neoplasms
  • Veliparib + VX-970 + Cisplatin
  • Bethesda, Maryland
  • +2 more
Jan 14, 2022

Invasive Group B Streptococcus Disease Burden and Its

Recruiting
  • Invasive Infection
  • +3 more
  • No Intervention in This study
  • Serdang, Selangor, Malaysia
    Faculty of Medicine and Health Sciences
Feb 11, 2023

Achilles Tendon Rupture, Physical Disability Trial in Mölndal (Neuromuscular electrical stimulation (NMES))

Not yet recruiting
  • Achilles Tendon Rupture
  • Physical Disability
  • Neuromuscular electrical stimulation (NMES)
  • Mölndal, VGregion, Sweden
    Forskningsenhet Ortopedi, Sahlgrenska universitetssjukhuset, Möl
Aug 18, 2023

ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

Recruiting
  • ARID1A Gene Mutation
  • +15 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical Trial in United States (Sham comparator, DrugSorb-ATR

Recruiting
  • Hemorrhage, Surgical
  • +3 more
  • Sham comparator
  • DrugSorb-ATR system
  • Sacramento, California
  • +23 more
Jul 20, 2022

NSCLC Trial in Pittsburgh (M1774, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Cancer Center
May 22, 2023

Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL) Trial in United Kingdom (SRA737)

Completed
Has Results
  • Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
  • Sutton, London, United Kingdom
  • +14 more
Mar 9, 2022

Advanced Solid Tumor Trial in Canada, Denmark, United States (RP-6306, RP-3500)

Recruiting
  • Advanced Solid Tumor
  • New Haven, Connecticut
  • +11 more
Apr 25, 2022